Drug prescription in pregnancy: analysis of a large statutory sickness fund populationEGEN-LAPPE, Veronika; HASFORD, Joerg.European journal of clinical pharmacology. 2004, Vol 60, Num 9, pp 659-666, issn 0031-6970, 8 p.Article

An intranet database for a university hospital drug information centerDUGAS, Martin; WEINZIERL, Sonja; PECAR, Alenka et al.American journal of health-system pharmacy. 2001, Vol 58, Num 9, pp 799-802, issn 1079-2082Article

A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch: Cohort study on smoking cessationHASFORD, Joerg; FAGERSTROM, Karl Olov; HAUSTEIN, Knut-Olav et al.European journal of clinical pharmacology. 2003, Vol 59, Num 5-6, pp 443-447, issn 0031-6970, 5 p.Article

A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemiaHÖRBRAND, Franziska; BRAMLAGE, Peter; FISCHALECK, Johann et al.European journal of clinical pharmacology. 2013, Vol 69, Num 4, pp 929-936, issn 0031-6970, 8 p.Article

Drug-Induced Blood Consumption: The Impact of Adverse Drug Reactions on Demand for Blood Components in German Departments of Internal MedicineROTTENKOLBER, Dominik; SCHMIEDL, Sven; ROTTENKOLBER, Marietta et al.Basic & clinical pharmacology & toxicology (Print). 2012, Vol 111, Num 4, pp 240-247, issn 1742-7835, 8 p.Article

The association of psychosocial factors with nausea and vomiting during pregnancyMARKL, Gertraud E; STRUNZ-LEHNER, Christine; EGEN-LAPPE, Veronika et al.Journal of psychosomatic obstetrics and gynaecology. 2008, Vol 29, Num 1, pp 17-22, issn 0167-482X, 6 p.Article

Persistence with antihypertensive treatments : results of a 3-year follow-up cohort studyHASFORD, Joerg; SCHRÖDER-BERNHARDI, Detlef; ROTTENKOLBER, Marietta et al.European journal of clinical pharmacology. 2007, Vol 63, Num 11, pp 1055-1061, issn 0031-6970, 7 p.Article

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: Results of a prospective randomized trial of the German Low Grade Lymphoma Study GroupLENZ, Georg; DREYLING, Martin; SCHIEGNITZ, Eva et al.Journal of clinical oncology. 2004, Vol 22, Num 24, pp 4926-4933, issn 0732-183X, 8 p.Article

The Follicular Lymphoma International Prognostic index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcomeBUSKE, Christian; HOSTER, Eva; DREYLING, Martin et al.Blood. 2006, Vol 108, Num 5, pp 1504-1508, issn 0006-4971, 5 p.Article

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IVHEHLMANN, Rüdiger; MÜLLER, Martin C; SCHNITTGER, Susanne et al.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 415-423, issn 0732-183X, 9 p.Article

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphomaHOSIER, Eva; DREYLING, Martin; PETER, Norma et al.Blood. 2008, Vol 111, Num 2, pp 558-565, issn 0006-4971, 8 p.Article

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma : results of a prospective randomized trial of the european MCL networkDREYLING, Martin; LENZ, Georg; BOIRON, Jean-Michel et al.Blood. 2005, Vol 105, Num 7, pp 2677-2684, issn 0006-4971, 8 p.Article

Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admissions: Results of a Prospective, Long-Term Multi-Centre StudySCHMIEDL, Sven; ROTTENKOLBER, Marietta; HASFORD, Joerg et al.Drug safety. 2014, Vol 37, Num 4, pp 225-235, issn 0114-5916, 11 p.Article

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVFABARIUS, Alice; LEITNER, Armin; JUNG-MUNKWITZ, Susanne et al.Blood. 2011, Vol 118, Num 26, pp 6760-6768, issn 0006-4971, 9 p.Article

Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersBONIFAZI, Francesca; DE VIVO, Antonio; KLUIN-NELEMANS, Hanneke C et al.Blood. 2001, Vol 98, Num 10, pp 3074-3081, issn 0006-4971Article

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid LeukemiaHEHLMANN, Rüdiger; LAUSEKER, Michael; HÄNEL, Mathias et al.Journal of clinical oncology. 2011, Vol 29, Num 12, pp 1634-1642, issn 0732-183X, 9 p.Article

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IVSAUSSELE, Susanne; LAUSEKER, Michael; SCHLIMOK, Günter et al.Blood. 2010, Vol 115, Num 10, pp 1880-1885, issn 0006-4971, 6 p.Article

BQuality /BbAssessment /Bbin /BbMultiple /BbSclerosis/BbTherapy /Bb(QUASIMS)/B : a comparison of interferon beta therapies for relapsing-remitting multiple sclerosisLIMMROTH, Volker; MALESSA, Rolf; BROSIG, Arne et al.Journal of neurology. 2007, Vol 254, Num 1, pp 67-77, issn 0340-5354, 11 p.Article

Booster vaccination in the elderly : Their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titersKAMI, Maria; WEISKIRCHNER, Ilka; NEUMAN, Ber et al.Vaccine. 2006, Vol 24, Num 47-48, pp 6808-6811, issn 0264-410X, 4 p.Article

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)LENZ, Georg; DREYLING, Martin; MARTIN, Sonja et al.Journal of clinical oncology. 2005, Vol 23, Num 9, pp 1984-1992, issn 0732-183X, 9 p.Article

The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferonHASFORD, Joerg; PFIRRMANN, Markus; SHEPHERD, Pat et al.Haematologica (Roma). 2005, Vol 90, Num 3, pp 335-340, issn 0390-6078, 6 p.Article

Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML IntergroupBÜCHNER, Thomas; SCHLENK, Richard F; SPÄTH, Daniela et al.Journal of clinical oncology. 2012, Vol 30, Num 29, pp 3604-3610, issn 0732-183X, 7 p.Article

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreHASFORD, Joerg; BACCARANI, Michele; SIMONSSON, Bengt et al.Blood. 2011, Vol 118, Num 3, pp 686-692, issn 0006-4971, 7 p.Article

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemiaMESSERER, Dorle; ENGEL, Jutta; KRAUTER, Jürgen et al.Haematologica (Roma). 2008, Vol 93, Num 6, pp 826-833, issn 0390-6078, 8 p.Article

Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. CommentaryGUILHOT, Francois; HEHLMANN, Rüdiger; REITER, Andreas et al.Blood. 2007, Vol 109, Num 11, issn 0006-4971, 4592, 4686-4692 [8 p.]Article